Abstract
Editorials1 August 1974Thalassemia Major: A Problem of Iron OverloadJAMES A. STOCKMAN III, FRANK A. OSKIJAMES A. STOCKMAN IIISearch for more papers by this author, FRANK A. OSKISearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-81-2-262 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptIt has long been recognized that the palliative treatment of beta thalassemia major is ultimately little more than the substitution of one form of chronic disease (iatrogenic iron overload), and death, for the short life associated with the natural course of the disorder. With a point d'appui for definitive therapy not yet established, the concern of the physician would be optimally focused on those factors that can reduce the burden to the body of iron and its effects on many organ systems.Desferrioxamine, shown over a decade ago to effectively chelate iron, was expected to be useful in iron overload...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
